➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
McKinsey
Express Scripts
Baxter
Dow

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Tobramycin sulfate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for tobramycin sulfate and what is the scope of patent protection?

Tobramycin sulfate is the generic ingredient in four branded drugs marketed by Lilly, Akorn, Apothecon, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Igi Labs Inc, Mylan Labs Ltd, Teva Pharms Usa, Watson Labs Inc, West-ward Pharms Int, Xellia Pharms Aps, and Xgen Pharms, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for tobramycin sulfate. Six suppliers are listed for this compound.

Recent Clinical Trials for tobramycin sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
McMaster UniversityPhase 4
University of Lausanne HospitalsN/A

See all tobramycin sulfate clinical trials

Pharmacology for tobramycin sulfate

US Patents and Regulatory Information for tobramycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 065122-002 Nov 29, 2002 AP RX No Yes   Start Trial   Start Trial   Start Trial
Apothecon TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 064026-001 May 31, 1994 DISCN No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 063118-001 Jul 29, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs Inc TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 062945-002 Aug 9, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
Igi Labs Inc TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 063119-001 Oct 31, 1994 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 063112-001 Apr 30, 1991 AP RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Moodys
Harvard Business School
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.